Table 1.
NHS | NHSII | |||
---|---|---|---|---|
Choline (n = 49,108) | Choline (n =74,453) | |||
Quintile | 1 | 5 | 1 | 5 |
Sample size | 8794 | 9838 | 14,251 | 14,966 |
Means | ||||
Age (years) | 59.1 | 61.5 | 39.5 | 40.9 |
Age at menarche (years) | 12.6 | 12.3 | 12.5 | 12.3 |
Parity (among parous women) | 3.2 | 3.1 | 2.2 | 2.2 |
Duration of oral contraceptive use (among users, months) | 24.1 | 25.4 | 50.3 | 51.2 |
Current body mass index (kg/m2) | 25.4 | 27.7 | 25.0 | 26.6 |
Height (meters) | 1.6 | 1.6 | 1.7 | 1.7 |
Caloric intake (kcal/day) | 1685 | 1693 | 1771 | 1778 |
Caffeine intake (mg/day) | 264 | 329 | 195 | 287 |
Alcohol consumption (g/day) | 6.0 | 5.5 | 2.7 | 3.6 |
Percentages | ||||
Parous | 94% | 93% | 75% | 79% |
Oral contraceptive use | 48% | 51% | 85% | 85% |
Premenopausalb | 13% | 12% | 95% | 95% |
Postmenopausalb | 87% | 88% | 2% | 3% |
Family history of ovarian cancerc | 3% | 3% | 2% | 2% |
History of tubal ligation | 21% | 21% | 22% | 24% |
Hysterectomy | 20% | 24% | 6% | 7% |
Current postmenopausal hormone user (among postmenopausal women) | 35% | 39% | 65% | 61% |
All factors except age were age-standardized in five-year intervals for each cohort. Results for quintiles of betaine are comparable (data not shown).
The percentages for premenopausal and postmenopausal do not add to 100% due to women with unknown menopausal status.
Mother or sister had ovarian cancer according to participant’s response on questionnaire; family history was evaluated using data from 1992 for NHS because it was not available in previous cycles.